Inoviq Ltd has released a press release.
Additional BARD1 Ovarian Test Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Grant of Japanese Patent
- Results of BARD1 ovarian cancer study
- Research and Development Update
- Appendix 4E Preliminary Financial Results
- Publication of BARD1 Lung Cancer Test
Later from Inoviq
- Israeli Patent Issued in Bard1 Core Patent Family
- Capital Raising
- Voluntary Suspension
- Contract Development Agreement Signed
- Improved Performance of BARD1 Ovarian Test
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq